Robbins LLP reminds investors of this

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of all purchasers of Inari Medical, Inc. (NASDAQ: NARI) common stock between February 24, 2022 and February 28 ) filed in , 2024. Inari is a medical technology company that specializes in the development, manufacture and marketing of catheter-based technologies for the treatment of venous thromboembolism (“VTE”), a condition that occurs when a vein, usually in the lower leg, develops. a blood clot forms. thigh or pelvis.

For more information, submit a form, email attorney Aaron Dumas, Jr., or call us at (800) 350-6003.

The accusations: Robbins LLP is investigating allegations that Inari Medical, Inc. (NARI) failed to disclose that bribes and kickbacks would negatively impact its financial results

According to the complaint, on February 29, 2024, Inari announced that the United States Department of Justice (“DOJ”) had received a civil investigative request regarding certain payments to healthcare professionals related to meals and consulting services, warning that “depending on the outcome of the Investigation could have a material impact on our business, results of operations or financial condition.” The complaint alleges that analysts downgraded the company’s stock in response. On this news, Inari’s stock price fell over $12 per share, or 21%, to close at $46.12 per share on February 29, 2024.

What now: You may be eligible to participate in the class action lawsuit against Inari Medical, Inc. Shareholders who wish to serve as lead plaintiffs in the class must file motions with the Court by July 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to be a party to the case to be eligible for compensation. If you choose to take no action, you may remain an absent student. For more information click Here.

All representations are made on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing press releases on this matter do not litigate securities class actions; Robbins LLP does this. As a recognized leader in shareholder litigation since 2002, Robbins LLP’s attorneys and staff have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold corporate executives accountable for their misconduct. Since our founding, we have raised over $1 billion for shareholders.

To be notified when a class action lawsuit against Inari Medical, Inc. is settled, or to receive free alerts when company executives commit misconduct, sign up Stock Monitoring Today.

Attorney advertising. Past results do not guarantee a similar result.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/350b006c-365c-41a1-97c5-550916857a98